X. Zhang, X. Guo, L. Fang, Y. Song, X. Fan
SHORT COMMUNICATION
are designated as s (singlet), d (doublet), t (triplet), q (quartet), m
(multiplet), and br. (broad). High-resolution mass spectra (HRMS)
were obtained by using a MicrOTOF mass spectrometer. All reac-
tions were monitored by thin-layer chromatography (TLC) by using
silica gel plates (silica gel 60 F254 0.25 mm), and components were
visualized by observation under UV light.
Changjiang Scholars and Innovative Research Team in University
(PCSIRT) (IRT 1061) for financial support.
[1] a) H. S. Chung, W. S. Woo, J. Nat. Prod. 2001, 64, 1579; b) C.
Ito, M. Itoigawa, A. Furukawa, T. Hirano, T. Murata, N.
Kaneda, Y. Hisada, K. Okuda, H. Furukawa, J. Nat. Prod.
2004, 67, 1800; c) J. P. Michael, Nat. Prod. Rep. 2008, 25, 166.
[2] B. Joseph, F. Darro, A. Béliard, B. Lesur, F. Collignon, C. De-
caestecker, A. Frydman, G. Guillaumet, R. Kiss, J. Med. Chem.
2002, 45, 2543.
[3] a) P. Cheng, Q. Zhang, Y.-B. Ma, Z.-Y. Jiang, X.-M. Zhang,
F.-X. Zhang, J.-J. Chen, Bioorg. Med. Chem. Lett. 2008, 18,
3787; b) B. C. Capell, M. Olive, M. R. Erdos, K. Cao, D. A.
Faddah, U. L. Tavarez, K. N. Conneely, X. Qu, H. San, S. K.
Ganesh, X. Chen, H. Avallone, F. D. Kolodgie, R. Virmani,
E. G. Nabel, F. S. Collins, Proc. Natl. Acad. Sci. USA 2008,
105, 15902.
[4] a) A. K. Gupta, N. Sabarwal, Y. P. Agrawal, S. Prachand, S.
Jain, Eur. J. Med. Chem. 2010, 45, 3472; b) B. S. Jayashree, S.
Thomas, Y. Nayak, Med. Chem. Res. 2010, 19, 193.
[5] a) I. Garrido-Laguna, F. Janku, G. S. Falchook, S. Fu, D. S.
Hong, A. Naing, J. Aaron, X. Wang, M. Kies, R. Kurzrock,
Clin. Cancer Res. 2010, 16, 4031; b) P. R. Angibaud, M. G.
Venet, W. Filliers, R. Broeckx, Y. A. Ligny, P. Muller, V. S. Pon-
celet, D. W. End, Eur. J. Org. Chem. 2004, 479.
[6] a) S. A. Neff, S. U. Lee, Y. Asami, J. S. Ahn, H. Oh, J. Baltru-
saitis, J. B. Gloer, D. T. Wicklow, J. Nat. Prod. 2012, 75, 464;
b) M.-A. Letellier, J. Guillard, D.-H. Caignard, G. Ferry, J. A.
Boutin, M.-C. Viaud-Massuard, Eur. J. Med. Chem. 2008, 43,
1730; c) M. J. Walsh, K. R. Brimacombe, H. Veith, J. M. Bou-
gie, T. Daniel, W. Leister, L. C. Cantley, W. J. Israelsen, M. G.
Vander Heiden, M. Shen, D. S. Auld, C. J. Thomas, M. B.
Boxer, Bioorg. Med. Chem. Lett. 2011, 21, 6322.
[7] a) T. Bach, H. Bergmann, B. Grosch, K. Harms, J. Am. Chem.
Soc. 2002, 124, 7982; b) R. Kumabea, H. Nishino, Tetrahedron
Lett. 2004, 45, 703; c) A. F. Morel, E. L. Larghi, M. M. Sel-
vero, Synlett 2005, 2755; d) A. Chilin, C. Marzano, F. Baccich-
etti, M. Simonato, A. Guiotto, Bioorg. Med. Chem. 2003, 11,
1311; e) T. N. Glasnov, W. Stadlbauer, C. O. Kappe, J. Org.
Chem. 2005, 70, 3864.
General Procedure for the Preparation of 3-Cyanoquinolin-2-ones 4:
To a flask containing a solution of 3-(2-bromophenyl)-2-cyano-
propanamide 3 (0.5 mmol) in ethylene glycol (3 mL) was added CuI
(190 mg, 0.1 mmol), l-proline (11.5 mg, 0.1 mmol), and K2CO3
(138 mg, 1.0 mmol). Then, the mixture was stirred at 110 °C for
10 h. After cooling the reaction mixture to room temperature,
water (10 mL) was added. The mixture was extracted with ethyl
acetate. The combined organic layer was washed with brine and
then dried with anhydrous Na2SO4. The solvent was evaporated
under vacuum, and the crude product was purified by chromatog-
raphy on silica gel to afford 3-cyanoquinolin-2-ones 4.
General Procedure for the Preparation of 3-(2-Bromobenzyl)-3-
cyano-3,4-dihydroquinolin-2-ones 5: To a flask containing a solution
of 2-bromobenzyl bromide (3 mmol) and cyanoacetamide (84 mg,
1 mmol) in ethylene glycol (5 mL) was added CuI (380 mg,
0.2 mmol) and K2CO3 (415 mg, 3 mmol). Then, the mixture was
stirred at 110 °C for 2 h. After cooling the reaction mixture to room
temperature, water (10 mL) was added. The mixture was extracted
with ethyl acetate. The combined organic layer was washed with
brine and then dried with anhydrous Na2SO4. The solvent was
evaporated under vacuum, and the crude product was purified by
chromatography on silica gel to afford 3-(2-bromobenzyl)-3-cyano-
3,4-dihydro quinolin-2-ones 5.
General Procedure for the Preparation of 3-(2-Bromobenzyl)quin-
olin-2-ones 6: To
a flask containing a solution of 3-(2-
bromobenzyl)-3-cyano-3,4-dihydroquinolin-2-one 5 (1 mmol) in
DMSO (5 mL) was added sodium methoxide (162 mg, 3 mmol).
Then, the mixture was stirred at 110 °C for 2 h. After cooling the
reaction mixture to room temperature, water (10 mL) was added.
The mixture was extracted with ethyl acetate. The combined or-
ganic layer was washed with H2O and brine and then dried with
anhydrous Na2SO4. The solvent was evaporated under vacuum,
and the crude product was purified by chromatography on silica
gel to afford 3-(2-bromobenzyl)quinolin-2-ones 6.
[8] a) D. B. Guthrie, S. J. Geib, D. P. Curran, J. Am. Chem. Soc.
2009, 131, 15492; b) J. Horn, H. Li, S. P. Marsden, A. Nelson,
R. J. Shearer, A. J. Campbell, D. House, G. G. Weingarten, Tet-
rahedron 2009, 65, 9002; c) W. Zhou, L. Zhang, N. Jiao, Tetra-
hedron 2009, 65, 1982.
[9] a) B. A. Kulkarni, A. Ganesan, Chem. Commun. 1998, 785; b)
K. Li, L. N. Foresee, J. A. Tunge, J. Org. Chem. 2005, 70, 2881;
c) J. T. Kuethe, A. Wong, I. W. Davies, Org. Lett. 2003, 5, 3975;
d) J. M. Fourquez, A. Godard, F. Marsais, G. Quéguiner, J.
Heterocycl. Chem. 1995, 32, 1165; e) G. M. Coppolar, G. E.
Hardtmann, J. Heterocycl. Chem. 1979, 16, 1605.
[10] a) C. Jia, Y. Dong, S. Tu, G. Wang, Tetrahedron 2007, 63, 892;
b) P. Hewawasam, W. Fan, J. Knipe, S. L. Moon, C. G. Bois-
sard, V. K. Gribkoff, J. E. Starrett Jr., Bioorg. Med. Chem. Lett.
2002, 12, 1779; c) L. Ismaili, A. Nadaradjane, L. Nicod, C.
Guyon, A. Xicluna, J. Robert, B. Refouvelet, Eur. J. Med.
Chem. 2008, 43, 1270; d) K. Wang, E. Herdtweck, A. Dömling,
ACS Comb. Sci. 2012, 14, 316.
[11] a) D. V. Kadnikov, R. C. Larock, J. Organomet. Chem. 2003,
687, 425; b) D. V. Kadnikov, R. C. Larock, J. Org. Chem. 2004,
69, 6772; c) P. J. Manley, M. T. Bilodeau, Org. Lett. 2004, 6,
2433; d) M. G. Banwell, D. W. Lupton, X. Ma, J. Renner,
M. O. Sydnes, Org. Lett. 2004, 6, 2741; e) M. Wasa, J.-Q. Yu,
J. Am. Chem. Soc. 2008, 130, 14058; f) A. C. Tadd, A. Mat-
suno, M. R. Fielding, M. C. Willis, Org. Lett. 2009, 11, 583; g)
Z. Liu, C. Shi, Y. Chen, Synlett 2008, 1734; h) R. Bernini, S.
Cacchi, G. Fabrizi, A. Sferrazza, Heterocycles 2006, 69, 99; i)
K. Inamoto, T. Saito, K. Hiroya, T. Doi, J. Org. Chem. 2010,
75, 3900; j) K. Inamoto, J. Kawasaki, K. Hiroya, Y. Kondo, T.
Doi, Chem. Commun. 2012, 48, 4332; k) X. Liu, X. Xin, D.
General Procedure for the Preparation of 12H-Chromeno[2,3-b]quin-
olin-12-ones 7: To a flask containing a solution of 3-(2-bromo-
benzyl)quinolin-2-one 6 (0.5 mmol) in DMF (3 mL) was added CuI
(190 mg, 0.1 mmol) and K2CO3 (138 mg, 1.0 mmol). Then, the
mixture was stirred at 110 °C for 10 h. After cooling the reaction
mixture to room temperature, water (10 mL) was added. The mix-
ture was extracted with ethyl acetate. The combined organic layer
was washed with brine, dried, and then evaporated under vacuum.
The crude product was purified by chromatography on silica gel to
afford 12H-chromeno[2,3-b]quinolin-12-ones 7.
Supporting Information (see footnote on the first page of this arti-
1
cle): Experimental details; characterization data; copies of the H
NMR and 13C NMR spectra of 4a–o, 5a–l, 6a–f, and 7a–f; and the
X-ray crystal structure of 5a.
Acknowledgments
The authors are grateful to the National Natural Science Founda-
tion of China (NSFC) (grant numbers 21272058, 21172057), the
Research Fund for the Doctoral Program of Higher Education
(RFDP) (grant number 20114104110005), and the Program for
8092
www.eurjoc.org
© 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2013, 8087–8093